A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

Clinical trial NCT06920004 · RECRUITING

Trial details

NCT number: NCT06920004
Sponsor: argenx
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Inflammatory Demyelinating Polyneuropathy CIDP CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Start date: 2025-08-22
Primary completion: 2027-09-01
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.